A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma.
about
Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overviewNeoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesCXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brainRole of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric PlerixaforHypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus.Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapyChemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancerThe therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.Clinical utilization of chemokines to combat cancer: the double-edged sword.The tumor microenvironment: key to early detection.The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.Cancer stem cells and human malignant melanomaChemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.The good and the bad of chemokines/chemokine receptors in melanoma.Targeted drug delivery strategies to treat lung metastasis.Chemokines in tumor-associated angiogenesis.The role of stromal-derived factor-1--CXCR7 axis in development and cancer.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).The successes and failures of HIV drug discovery.A future perspective on the development of chemokine receptor CXCR4 antagonists.Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer.TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.CXCR4 in Cancer and Its Regulation by PPARgamma.The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer.Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
P2860
Q26774619-93E1B81C-017E-4A1E-843E-F13C7BD7E922Q27001081-0541CB91-5862-47F0-911C-B7C84E2C2973Q27009526-034BA952-9FF6-4D2C-8ED5-BC96366B1506Q33559560-964CBD91-548B-4B02-A821-42E01CB7FDF8Q33685045-5FA8AA8A-82C0-4C7D-AC03-FDA8F914375AQ33687703-D8CFB78D-99A1-4E28-AABF-05F68401DBBEQ33829094-400ECCD2-7D01-405D-B1A4-3E813E633EB8Q34157254-832E72C7-D100-4404-B18D-313DAF38B780Q34552894-DCA41433-61B3-4DBC-89E1-782B58183935Q36280164-C9478B72-673D-4BCF-B9FF-15F325DDAC3DQ36318564-2077EC20-0240-440A-BDFD-37FC19738303Q36488894-B684B4BB-4D01-458B-AF47-27C9A34E0335Q36627750-0F197686-F831-4C21-A4AF-AAEA68959EA1Q36800490-4B01DAF0-7206-4DB7-9A7E-028967BF53FAQ36951239-FF56EB5B-396D-4282-8918-6B7BC282D695Q37114128-4D054A8D-EF79-45E8-9C6D-55FE5AAFD20DQ37351199-2F18CAB1-BC2F-42E0-91A8-E17BC28B69BCQ37352728-59A194E1-1FB4-48F6-857A-376310B90CF4Q37394981-7C3BC4B6-3459-45F3-BD62-601D146C6510Q37575499-F29C1592-6670-4B97-80C3-5902E847FB77Q37608615-6AC87EF1-373B-4504-BE56-CD27826319E7Q37616298-99AE710A-DEB8-48EB-ACA8-7DE6F37F662BQ38003847-287B498C-2A4A-4335-9E05-D6FAE3EDBE86Q38014557-B435EBF7-E94D-4534-A1F8-C68E40B08CF9Q38089173-75F2CBA9-D560-4F83-82A0-A162190BAFACQ38776802-3C63DCF7-99F6-4E03-934D-F56A1AA47CC1Q38818844-8960DFDD-7DEB-49C8-9DC1-B09978B6C46CQ42007327-9A3BFE54-6621-47B2-A81F-29893D742F1EQ42737221-EF9F2297-8DB3-4694-9CA8-13B560C7191EQ54595543-7619E709-1024-41A9-BF2A-58D8B1B28D2B
P2860
A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A single treatment with microc ...... metastasis of murine melanoma.
@en
type
label
A single treatment with microc ...... metastasis of murine melanoma.
@en
prefLabel
A single treatment with microc ...... metastasis of murine melanoma.
@en
P2093
P1476
A single treatment with microc ...... metastasis of murine melanoma.
@en
P2093
A Kitagawa
H Nakashima
H Tamamura
K Hiramatsu
M Takenaga
N Nakamura
R Igarashi
Y Yamaguchi
P304
P356
10.1016/J.BBRC.2004.05.155
P577
2004-07-01T00:00:00Z